66
Participants
Start Date
June 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Sofosbuvir
Sofosbuvir 400 mg tablet administered orally once daily
RBV
Ribavirin (RBV) tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)
Pittsburgh
Philadelphia
Baltimore
Richmond
Durham
Decatur
Miami
Kansas City
Dallas
Houston
Los Angeles
Long Beach
San Diego
San Francisco
Palo Alto
Portland
New Haven
Lead Sponsor
Gilead Sciences
INDUSTRY